Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management

I Nazari, MJ Feinstein - Clinical Microbiology Reviews, 2024 - Am Soc Microbiol
People with HIV (PWH) are at elevated risk for cardiovascular diseases (CVDs), including
myocardial infarction, heart failure, and sudden cardiac death, among other CVD …

Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities

T Awamura, ES Nakasone, LM Gangcuangco… - Biomolecules, 2023 - mdpi.com
Platelets are anucleate cytoplasmic cell fragments that circulate in the blood, where they are
involved in regulating hemostasis. Beyond their normal physiologic role, platelets have …

[HTML][HTML] Prevention and Treatment of Cardiovascular Disease in HIV: Practical Insights in an Evolving Field

H Avgousti, MJ Feinstein - Topics in antiviral medicine, 2023 - ncbi.nlm.nih.gov
People with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people
without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so …

[HTML][HTML] Cardiovascular Prevention in People Living With HIV: Is There a Rationale to Move Beyond Aspirin?

J Silvain, M Kerneis, F Boccara - Basic to Translational Science, 2022 - jacc.org
HIV (PWHIV) in the United States were estimated to be 1.2 million people aged 13 years and
older with approximately 35,000 to 40,000 new HIV infections per year. Antiretrovirals …

[HTML][HTML] Emerging Clinical Problem of Resistance to Antiplatelet Therapy in Primary Prevention and Treatment of Cardiovascular Events in People Living with HIV …

G Ogweno, E Kimathi - 2023 - intechopen.com
Despite the extensive use of combined antiretroviral therapy (cART) for effective human
immunodeficiency viral (HIV) suppression, people living with HIV have an increased risk of …